Please use this identifier to cite or link to this item: http://doi.org/10.25358/openscience-7828
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBinder, Harald-
dc.contributor.authorKurz, Thorsten-
dc.contributor.authorTeschner, Sven-
dc.contributor.authorKreutz, Clemens-
dc.contributor.authorGeyer, Marcel-
dc.contributor.authorDonauer, Johannes-
dc.contributor.authorKraemer-Guth, Annette-
dc.contributor.authorTimmer, Jens-
dc.contributor.authorSchumacher, Martin-
dc.contributor.authorWalz, Gerd-
dc.date.accessioned2022-10-05T08:08:14Z-
dc.date.available2022-10-05T08:08:14Z-
dc.date.issued2016
dc.identifier.urihttps://openscience.ub.uni-mainz.de/handle/20.500.12030/7843-
dc.description.abstractBackground Identification of prognostic gene expression markers from clinical cohorts might help to better understand disease etiology. A set of potentially important markers can be automatically selected when linking gene expression covariates to a clinical endpoint by multivariable regression models and regularized parameter estimation. However, this is hampered by instability due to selection from many measurements. Stability can be assessed by resampling techniques, which might guide modeling decisions, such as choice of the model class or the specific endpoint definition. Methods We specifically propose a strategy for judging the impact of different endpoint definitions, endpoint updates, different approaches for marker selection, and exclusion of outliers. This strategy is illustrated for a study with end-stage renal disease patients, who experience a yearly mortality of more than 20 %, with almost 50 % sudden cardiac death or myocardial infarction. The underlying etiology is poorly understood, and we specifically point out how our strategy can help to identify novel prognostic markers and targets for therapeutic interventions. Results For markers such as the potentially prognostic platelet glycoprotein IIb, the endpoint definition, in combination with the signature building approach is seen to have the largest impact. Removal of outliers, as identified by the proposed strategy, is also seen to considerably improve stability. Conclusions As the proposed strategy allowed us to precisely quantify the impact of modeling choices on the stability of marker identification, we suggest routine use also in other applications to prevent analysis-specific results, which are unstable, i.e. not reproducible.en_GB
dc.description.sponsorshipDFG, Open Access-Publizieren Universität Mainz / Universitätsmedizinde
dc.language.isoengde
dc.rightsCC BY*
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subject.ddc610 Medizinde_DE
dc.subject.ddc610 Medical sciencesen_GB
dc.titleDealing with prognostic signature instability : a strategy illustrated for cardiovascular events in patients with end-stage renal diseaseen_GB
dc.typeZeitschriftenaufsatzde
dc.identifier.doihttp://doi.org/10.25358/openscience-7828-
jgu.type.dinitypearticleen_GB
jgu.type.versionPublished versionde
jgu.type.resourceTextde
jgu.organisation.departmentFB 04 Medizinde
jgu.organisation.number2700-
jgu.organisation.nameJohannes Gutenberg-Universität Mainz-
jgu.rights.accessrightsopenAccess-
jgu.journal.titleBMC medical genomicsde
jgu.journal.volume9de
jgu.journal.issue1de
jgu.pages.alternativeArt. 43de
jgu.publisher.year2016-
jgu.publisher.nameBioMed Centralde
jgu.publisher.placeLondonde
jgu.publisher.urihttp://dx.doi.org/10.1186/s12920-016-0210-9de
jgu.publisher.issn1755-8794de
jgu.organisation.placeMainz-
jgu.subject.ddccode610de
opus.date.modified2018-08-23T08:38:39Z
opus.subject.dfgcode00-000
opus.organisation.stringFB 04: Medizin: Institut für Med. Biometrie, Epidemologie und Informatikde_DE
opus.identifier.opusid56381
opus.institute.number0424
opus.metadataonlyfalse
opus.type.contenttypeKeinede_DE
opus.type.contenttypeNoneen_EN
opus.affiliatedBinder, Harald
jgu.publisher.doi10.1186/s12920-016-0210-9de
jgu.organisation.rorhttps://ror.org/023b0x485-
Appears in collections:DFG-OA-Publizieren (2012 - 2017)

Files in This Item:
  File Description SizeFormat
Thumbnail
dealing_with_prognostic_signa-20220914003115661.pdf1.33 MBAdobe PDFView/Open